Starting this month and over the next couple of months, researchers will be moving into a $200 million, 237,000-square-foot building that blends research and some clinical space to treat patients with various brain and central nervous system disorders, such as Alzheimer's disease, multiple sclerosis and amyotrophic lateral sclerosis.
No comments:
Post a Comment